Table 2. DA.PVG-Eae23 is protected from EAE compared to DA.
Females Mean (SD) | Males Mean (SD) | |||
DA (N = 12) | D.P-Eae23 (N = 13) | DA (N = 22) | D.P-Eae23 (N = 21) | |
Incidence | 92% | 69% | 82% | 76% |
Day of Onset | 14.8 (8.3) | 22.5 (12.9) | 19.6 (10.4) | 21.9 (11.3) |
Max EAE Score | 2.8 (1.4) | 1.5 (1.3)* | 2.6 (1.6) | 1.7 (1.2)* |
Duration | 19.7 (8.6) | 10.1 (9.5)* | 15.8 (8.9) | 11.7 (10.2) |
Cumulative EAE score | 50.7 (32.7) | 15.0 (17.0)** | 38 (28) | 23 (23.9) |
Mann-Whitney U-test was used to compare clinical phenotypes between parental DA and DA.PVG-Eae23; p values ≤0.05 were considered significant, indicated by
* = p<0.05;
** = p<0.01. Abbreviations: SD = standard deviation.